Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P840001/S635

Master Restore, Itrel, Synergy Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify,

Medtronic Neuromodulation · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONP840001/S635

What did the FDA decide?

FDA posted a 30-day notice for PMA supplement S635 to P840001, covering Medtronic Neuromodulation spinal cord stimulation systems and leads. The dated statement lists six manufacturing process changes: enhanced operator verification of a FactoryWorks processing step and recorded battery pre-weight; addition of pre-weight and post-weight out-of-control action plans to Process Operation Descriptions; software and human machine interface updates that automatically reject batteries with fill weights above the established final-fill reasonable limit; introduction of dedicated white work-in-progress trays to distinguish electrolyte-filled batteries; use of an isopropyl alcohol wipe to remove residual electrolyte from battery surfaces; and removal of Ball Press and Button Press certification prerequisites from the ram change procedure.

The notice is a process change supplement, not a new approval of the whole system or an original PMA. The statement reports the intended purpose of the changes, such as improving line clearance, handling, and traceability, but does not independently establish safety or clinical effectiveness. No clinical indication, trial data, or benefit assessment is included. The source does not state whether these changes affect device labeling or performance specifications.

FDA approval order statement

1. Enhanced operator verification of the applicable FactoryWorks processing step and recorded battery pre-weight.2. Addition of pre-weight and post-weight out-of-control action plans to the applicable Process Operation Descriptions.3. Software and Human Machine Interface updates that will automatically reject batteries with fill weights above the established final-fill reasonable limit.4. Introduction of dedicated white work-in-progress trays to distinguish electrolyte-filled batteries and improve line clearance, handling, and traceability.5. Use of an isopropyl alcohol wipe to remove residual electrolyte from battery surfaces before subsequent processing.6. Removal of the Ball Press and Button Press certification prerequisites from the Ball and Button Press Ram Change procedure, allowing Medium Rate Line 2 operators to qualify for press ram changes by completing only the ram-change procedure while supervisors and engineers retain responsibility for operator certification
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 29, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P840001/S635
Regulatory pathway
PMA supplement
Product code
LGW
Decision code
OK30
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

For the original device and its historical approval scope, see PMA P840001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P840001 · Original PMA

    ITREL(R) TOTALLY IMPLANTABLE SPINAL CORD STIM. SYS

  2. P840001/S634 · Related supplement

    Vantawith AdaptiveStim Technology - Model 977006

  3. P840001/S635 received

    Application receipt date recorded by FDA.

  4. P840001/S632 · Related supplement

    Master Vanta with Restore, Itrel, Synergy, Intellis, AdaptiveStim Vanta and Inceptiv TM Spinal Cord Implantable S

  5. P840001/S635 · FDA decision

    30-Day Notice

  6. P840001/S636 · Related supplement

    Restore, Itrel, Synergy, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces-Quad, Specify,

Timeline entries are records held by MedtechLedger for P840001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P840001

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records